Gilead Sciences stock has received a consensus rating of hold. The average rating score is A3 and is based on 17 buy ratings, 43 hold ratings, and 3 sell. GILD - Gilead Sciences, Inc. ; No. of Analysts, 20, 18 ; Avg. Estimate, , ; Low Estimate, , ; High Estimate, , Ad Feedback. GILD Forecasts. Facts. analyst rating. buy; hold; sell. We're sorry, but this information is temporarily unavailable. 1-year stock price forecast. Strong Buy = 5; Moderate Buy = 4; Hold = 3; Moderate Sell = 2; Strong Sell = 1. Ratings Breakdown. 3 Mths Ago. Moderate Buy. Based on 24 analysts. Chart. * Earnings are based on GAAP income from continuing operations. Average Analyst Ratings. Rating. Strong.
Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue. Based on short-term price targets offered by 24 analysts, the average price target for Gilead Sciences comes to $ The forecasts range from a low of $ Average Recommendation, Overweight ; Average Target Price, ; Number Of Ratings, 30 ; FY Report Date, 12/ ; Last Quarter's Earnings, The consensus among 12 Wall Street analysts covering (NASDAQ: GILD) stock is to Buy GILD stock. Out of 12 analysts, 1 (%) are recommending GILD as a Strong. Gilead Sciences Inc. research and ratings by Barron's. View GILD revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. GILD - Gilead Sciences, Inc. ; No. of Analysts, 20, 18 ; Avg. Estimate, , ; Low Estimate, , ; High Estimate, , %. Analyst Ratings. Average price target from 30 ratings: $ Average score: Sell. Under. Hold. Over. Buy. Full Ratings · StockGrader. Rating: Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our. Analyst Reco. Gilead Sciences, Inc. Equities. GILD. US Real-time Estimate Cboe BZX. We've gathered opinions of 30 analysts rating GILD stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other. Get Wall Street analysts ratings for Gilead Sciences, Inc. (GILD). Buy or Sell this stock? See what the analysts say.
Analyst Ratings. The average analyst rating for GILD stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to. Analyst Price Targets ; with a high estimate of ; 95 and a low estimate of ; Sign in to your SmartPortfolio to see more analyst recommendations. Analysts' Consensus ; Mean consensus. OUTPERFORM ; Number of Analysts. 29 ; Last Close Price. USD ; Average target price. USD ; Spread / Average Target. +. Gilead Sciences Inc (GILD) · Volume: 5,, · Bid/Ask: / · Day's Range: - Based on 20 Wall Street analysts who have issued ratings for Gilead Sciences in the last 12 months, the stock has a consensus rating of "Hold." Out of the The company's average rating score is , and is based on 7 buy ratings, 12 hold ratings, and no sell ratings. Amount of Analyst Coverage. Gilead Sciences has. Gilead Sciences Inc has a consensus price target of $ based on the ratings of 26 analysts. The high is $ issued by Piper Sandler on February 3, According to analysts, GILD price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. The company's average rating score is , and is based on 7 buy ratings, 12 hold ratings, and no sell ratings. Amount of Analyst Coverage. Gilead Sciences has.
RBC Capital has maintained a Sector Perform rating for Gilead Sciences, Inc. and increased its price target to $ per share from a previous target of $ No. of Analysts, 18, 17 ; Avg. Estimate, B · B ; Low Estimate, B · B ; High Estimate, B · B. Hold ratings: 14, 14 ; Sell ratings: 0, 0 ; Strong sell ratings: 0, 0 ; Average rating: , GILD's average broker recommendation rating improved by over the prior 19 months. The bullet points below may help you gain a better understanding of what. * Earnings are based on GAAP income from continuing operations. Average Analyst Ratings. Rating. Strong.
Get the latest Gilead Sciences Inc. (GILD) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on dlyapohudenija.online, top-rated. OnAug 16, major Wall Street analysts update their ratings for $Gilead Sciences(dlyapohudenija.online)$, with price targets ranging from $76 to $Barclays analyst Carter.